Tectonic Therapeutic, Inc.(TECX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TECX Tectonic Therapeutic, Inc.

Pre-Mkt 10-16 06:16:24 EDT

21.30

+0.34

+1.62%

High21.51	Low21.06	Vol187.39K
Open21.08	D1 Closing20.96	Amplitude2.17%
Mkt Cap416.40M	Tradable Cap259.85M	Total Shares19.55M
T/O3.99M	T/O Rate1.54%	Tradable Shares12.20M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TECX","market":"US","secType":"STK","nameCN":"Tectonic Therapeutic, Inc.","latestPrice":21.3,"timestamp":1792094400000,"preClose":20.96,"halted":0,"volume":187393,"delay":0,"changeRate":0.01622137404580152,"floatShares":12199392,"shares":19549366,"eps":-4.56781,"marketStatus":"Pre-Mkt","change":0.34,"latestTime":"10-16 06:16:24 EDT","open":21.08,"high":21.5099,"low":21.055,"amount":3985140.76446,"amplitude":0.021703,"askPrice":34.08,"askSize":200,"bidPrice":8.57,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.56781,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1792157400000},"marketStatusCode":1,"adr":0,"listingDate":1529553600000,"exchange":"NASDAQ","adjPreClose":21.3,"postHourTrading":{"tag":"盘后","latestPrice":21.3,"preClose":21.3,"latestTime":"19:30 EDT","volume":3031,"amount":64560.43,"timestamp":1792107005536,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.2710866513141528,"impliedVol":0.688,"impliedVolPercentile":0.056},"requestUrl":"/m/hq/s/TECX/tweets","defaultTab":"tweets","newsList":[{"id":"2674037418","title":"UBS Initiates Coverage on Tectonic Therapeutic With Neutral Rating, $26 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2674037418","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674037418?lang=en_us&edition=fundamental","pubTime":"2026-10-12 22:05","pubTimestamp":1791813929,"startTime":"0","endTime":"0","summary":"Price: 23.08, Change: -0.25, Percent Change: -1.07","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674613803","title":"Tectonic Therapeutic Price Target Announced at $26.00/Share by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2674613803","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674613803?lang=en_us&edition=fundamental","pubTime":"2026-10-12 21:51","pubTimestamp":1791813060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TECX/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674417638","title":"UBS Initiates a Hold Rating on Tectonic Therapeutic (TECX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674417638","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674417638?lang=en_us&edition=fundamental","pubTime":"2026-10-12 06:57","pubTimestamp":1791759441,"startTime":"0","endTime":"0","summary":"In a report released today, from UBS initiated coverage with a Hold rating on Tectonic Therapeutic and a price target of $26.00. Currently, the ana...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-initiates-a-hold-rating-on-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-initiates-a-hold-rating-on-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749044","title":"Tectonic Therapeutic CSO Peter McNamara Disposes of 980 Common Shares Worth $22,812.48","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749044","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749044?lang=en_us&edition=fundamental","pubTime":"2026-10-03 05:01","pubTimestamp":1790974895,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic CSO Peter McNamara disposes of 980 common shares worth $22,812.48Tectonic Therapeutic Chief Scientific Officer Peter McNamara reduced his direct common stock stake to 54,305 share","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL6jjq6G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Tectonic Therapeutic CSO Peter McNamara Disposes of 980 Common Shares Worth $22,812.48","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672696677","title":"Tectonic Therapeutic Currently Down 13 Days Straight, on Pace for Record Losing Streak","url":"https://stock-news.laohu8.com/highlight/detail?id=2672696677","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672696677?lang=en_us&edition=fundamental","pubTime":"2026-10-02 01:32","pubTimestamp":1790875920,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic Inc.  is currently at $23.18, down $0.11 or 0.47%--Would be lowest close since March 2, 2026, when it closed at $23.00--On pace for largest percent decrease since Sept. 29, 2026, when it fell 0.72%--Currently down 13 consecutive days; down 21.98% over this period--Longest losing streak on record --Worst 13 day stretch since the 13 days ending Sept. 10, 2026, when it fell 23.97%--Up 11.12% year-to-date; on pace for best year since 2024, when it rose 182.9%--Down 96.33% from its all-time closing high of $632.40 on Sept. 26, 2018--Up 52% from 52 weeks ago , when it closed at $15.25--Down 38.89% from its 52-week closing high of $37.93 on July 2, 2026--Up 55.47% from its 52-week closing low of $14.91 on Oct. 7, 2025--Traded as low as $22.41; lowest intraday level since March 3, 2026, when it hit $21.70--Down 3.78% at today's intraday lowAll data as of 1:28:41 PM ETSource: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671724342","title":"Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Tectonic Therapeutic (TECX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671724342","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671724342?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:50","pubTimestamp":1790758222,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Abbott Laboratories (ABT), Tectonic Therapeutic (TEC...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-abbott-laboratories-abt-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-abbott-laboratories-abt-tectonic-therapeutic-tecx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IE00B2B36J28.USD","LABU","LU2237957811.SGD","BK4581","LU2468319806.SGD","SG9999004303.SGD","LU1061106388.HKD","LU1721429402.USD","LU1914381329.SGD","LU2112291526.USD","IE0002141913.USD","SGXZ23171101.USD","LU0266013472.USD","LU0128526141.USD","LU2089984988.USD","LU0058720904.USD","LU1721429741.USD","LU0868494617.USD","IHI","LU0289739699.SGD","BK4533","BK4568","LU1057294990.SGD","LU0122379950.USD","PJP","HCSG","LU0208291251.USD","TMED","XLV","ABT","BK4137","LU0211331839.USD","IE00BJJMRZ35.SGD","LU1670628061.USD","LU1989763690.USD","LU1023059063.AUD","LU2133065610.SGD","BK4139","LU0432979614.USD","LU0114720955.EUR","LU0320765489.SGD","SG9999002232.USD","XBI","BK4585","LU0170899867.USD","TECX","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671240398","title":"FDA Grants Tectonic Tx2100 Fast Track Status for HHT","url":"https://stock-news.laohu8.com/highlight/detail?id=2671240398","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671240398?lang=en_us&edition=fundamental","pubTime":"2026-09-30 05:20","pubTimestamp":1790716804,"startTime":"0","endTime":"0","summary":"FDA grants Tectonic TX2100 Fast Track status for HHTFDA granted Fast Track designation for TX2100 to treat hereditary hemorrhagic telangiectasia.Agency cleared an IND to start a Phase 1b U.S. trial in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL7YBT6C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671249477","title":"Tectonic Therapeutic on Track for Longest Losing Streak Since November 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2671249477","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671249477?lang=en_us&edition=fundamental","pubTime":"2026-09-30 01:37","pubTimestamp":1790703420,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic Inc  is currently at $23.16, down $0.35 or 1.47%--Would be lowest close since March 2, 2026, when it closed at $23.00--On pace for largest percent decrease since Sept. 25, 2026, when it fell 1.87%--Currently down 11 consecutive days; down 22.03% over this period--Longest losing streak since Nov. 19, 2021, when it fell for 12 straight trading days--Worst 11-day stretch since the 11 days ending Sept. 10, 2026, when it fell 24.13%--Down 22.63% month-to-date--Up 11.05% year-to-date--Down 96.34% from its all-time closing high of $632.40 on Sept. 26, 2018--Up 47.64% from 52 weeks ago , when it closed at $15.69--Down 38.93% from its 52-week closing high of $37.93 on July 2, 2026--Up 55.37% from its 52-week closing low of $14.91 on Oct. 7, 2025--Traded as low as $22.54; lowest intraday level since March 3, 2026, when it hit $21.70--Down 4.13% at today's intraday lowAll data as of 1:29:50 PM ETSource: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671453092","title":"Analyst Maintains Buy on TECX as TX2100 Advaces on Compressed Path to Proof-of-Concept; $88 Price Target Unchanged","url":"https://stock-news.laohu8.com/highlight/detail?id=2671453092","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671453092?lang=en_us&edition=fundamental","pubTime":"2026-09-29 23:25","pubTimestamp":1790695547,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Gaurav Maini maintained a Buy rating on Tectonic Therapeutic today and set a price target of $88.00. Gaurav Maini has given...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-tecx-as-tx2100-advaces-on-compressed-path-to-proof-of-concept-88-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-tecx-as-tx2100-advaces-on-compressed-path-to-proof-of-concept-88-price-target-unchanged-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211197","title":"Tectonic Therapeutic Reports Favorable Phase 1a Results for Tx2100 in HHT Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211197","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211197?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:07","pubTimestamp":1790683650,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic reports favorable Phase 1a results for TX2100 in HHT programTectonic Therapeutic reported favorable topline Phase 1a results for TX2100 in healthy volunteers, supporting advanceme","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL1QH71S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014013.SGD","SG9999014005.SGD","BCDF","IE00BQXX3C00.GBP","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","LU2095319765.USD","NDAQ","IE00BQXX3F31.USD","BK4112","LU2210150020.SGD","LU2210149790.SGD","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BK4139","BK4585","LU0314104364.USD","IE00BN0W2W23.USD","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211593","title":"Tectonic Therapeutic, - Tx2100 Trial Reported Only Mild or Moderate Transient Adverse Events; no Deaths or Serious Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211593","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211593?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA9VQ5BT:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211519","title":"Tectonic Therapeutic, - FDA Grants Fast Track Designation for Tx2100 in Hht and Clears Ind for Phase 1B Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211519","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211519?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA9VQ5BT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671211353","title":"Tectonic Therapeutic, - Tx2100 Phase 1a Trial Shows Single Ascending Doses Generally Safe and Well-Tolerated","url":"https://stock-news.laohu8.com/highlight/detail?id=2671211353","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671211353?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683205,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA9VQ5BT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671115112","title":"Tectonic Therapeutic, - Plans to Initiate Tx2100 Phase 1B Trial by Year-End 2026 and Phase 2 in Early 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2671115112","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671115112?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA9VQ5BT:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671113702","title":"Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and Pk Results for Tx2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (Hht)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671113702","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671113702?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683205,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA9VQ5BT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671021159","title":"Tectonic Therapeutic, - Pk Results Support Once Weekly and Every Other Week Subcutaneous Dosing Regimens","url":"https://stock-news.laohu8.com/highlight/detail?id=2671021159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671021159?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA9VQ5BT:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664771588","title":"Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664771588","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664771588?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"Investors:. Dan Ferry. LifeSci Advisors. (617) 430-7576. Media:. Kathryn Morris. The Yates Network. (914) 204-6412","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3355846/0/en/tectonic-therapeutic-to-participate-in-the-morgan-stanley-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0795875086.SGD","BK4534","IE00B3S45H60.SGD","LABU","LU1162221912.USD","LU1732800096.USD","LU0128526141.USD","BK4137","XBI","BK4516","LU1363072403.SGD","LU0106831901.USD","LU0557290698.USD","LU1548497426.USD","LU2271345857.HKD","BK4504","LU1988902786.USD","LU0528227936.USD","XLV","LU0029874061.USD","BK4127","LU2487616109.SGD","IE00B775SV38.USD","LU2089284900.SGD","LU0314104364.USD","KBWB","TECX","LU2264538146.SGD","LU1064131342.USD","IE00BKVL7J92.USD","MS","LU1668664300.SGD","LU2357305700.SGD","LU1244550221.USD","LU1791710582.SGD","LU0267386448.USD","LU1720051108.HKD","HCSG","LU1074936037.SGD","LU1720051017.SGD","BK4588","BK4585","LU2111349929.HKD","LU0158827948.USD","LU2028103732.USD","LU1244550494.USD","LU0210528500.USD","IAI","LU1989772923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664592778","title":"Tectonic Therapeutic (TECX) Gets a Buy from Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664592778","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664592778?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:36","pubTimestamp":1788266200,"startTime":"0","endTime":"0","summary":"Oppenheimer analyst reiterated a Buy rating on Tectonic Therapeutic today and set a price target of $80.00. Currently, the analyst consensus on Tec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/tectonic-therapeutic-tecx-gets-a-buy-from-oppenheimer-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/tectonic-therapeutic-tecx-gets-a-buy-from-oppenheimer-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663070458","title":"Tectonic Therapeutic (TECX) Receives a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2663070458","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663070458?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:36","pubTimestamp":1788176193,"startTime":"0","endTime":"0","summary":"In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Tectonic Therapeutic, with a price target of $76.00. Accor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/tectonic-therapeutic-tecx-receives-a-buy-from-piper-sandler-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/tectonic-therapeutic-tecx-receives-a-buy-from-piper-sandler-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TECX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662744799","title":"Tectonic Therapeutic CSO Peter McNamara Disposes of USD 1,570.36 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662744799","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662744799?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:32","pubTimestamp":1787776327,"startTime":"0","endTime":"0","summary":"Tectonic Therapeutic CSO Peter McNamara disposes of USD 1,570.36 in common sharesPeter McNamara, chief scientific officer at Tectonic Therapeutic, exercised options for 43 shares at USD 14.71 on Aug. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL5V9QVx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Tectonic Therapeutic CSO Peter McNamara Disposes of USD 1,570.36 in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TECX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tectonictx.com;investors.tectonictx.com","stockEarnings":[{"period":"1week","weight":-0.0637},{"period":"1month","weight":-0.2529},{"period":"3month","weight":-0.3466},{"period":"6month","weight":-0.2782},{"period":"1year","weight":0.2284},{"period":"ytd","weight":0.0211}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.019},{"period":"3month","weight":0.0383},{"period":"6month","weight":0.0868},{"period":"1year","weight":0.1603},{"period":"ytd","weight":0.1318}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.038483},{"month":2,"riseRate":0.5,"avgChangeRate":-0.005058},{"month":3,"riseRate":0.375,"avgChangeRate":-0.012026},{"month":4,"riseRate":0.125,"avgChangeRate":-0.086175},{"month":5,"riseRate":0.75,"avgChangeRate":0.079704},{"month":6,"riseRate":0.25,"avgChangeRate":-0.029433},{"month":7,"riseRate":0.555556,"avgChangeRate":0.096214},{"month":8,"riseRate":0.666667,"avgChangeRate":0.025871},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.057302},{"month":10,"riseRate":0.777778,"avgChangeRate":0.026122},{"month":11,"riseRate":0.5,"avgChangeRate":0.024692},{"month":12,"riseRate":0.5,"avgChangeRate":-0.049184}],"exchange":"NASDAQ","name":"Tectonic Therapeutic, Inc.","nameEN":"Tectonic Therapeutic, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tectonic Therapeutic, Inc.(TECX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tectonic Therapeutic, Inc.(TECX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tectonic Therapeutic, Inc.,TECX,Tectonic Therapeutic, Inc.股票,Tectonic Therapeutic, Inc.股票老虎,Tectonic Therapeutic, Inc.股票老虎国际,Tectonic Therapeutic, Inc.行情,Tectonic Therapeutic, Inc.股票行情,Tectonic Therapeutic, Inc.股价,Tectonic Therapeutic, Inc.股市,Tectonic Therapeutic, Inc.股票价格,Tectonic Therapeutic, Inc.股票交易,Tectonic Therapeutic, Inc.股票购买,Tectonic Therapeutic, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tectonic Therapeutic, Inc.(TECX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tectonic Therapeutic, Inc.(TECX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}